Status:
TERMINATED
Study Evaluating PSI-697 in Patients With Scleritis
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Scleritis
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
To evaluate the safety of an orally administered single dose of PSI-697 in subjects with scleritis, as a model of inflammatory disease. To evaluate by in vivo confocal microscopy (IVCM) the effect of ...
Eligibility Criteria
Inclusion
- Inclusion: Age 18 or higher; A negative urine pregnancy test at screening for female subjects; Female subjects must be postmenopausal or surgically sterile.
- Exclusion: Isolated episcleritis; Isolated posterior scleritis; Infectious scleritis.
Exclusion
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2007
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00367692
Start Date
September 1 2006
End Date
April 1 2007
Last Update
September 9 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.